Bexarotene Targretin - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Bexarotene Targretin

Description:

non-Hodgkins lymphoma composed of malignant T lymphocytes of the ... Bone marrow / Stem cell transplantation. Photopheresis. Treatment. Bexarotene (Targretin ... – PowerPoint PPT presentation

Number of Views:173
Avg rating:3.0/5.0
Slides: 33
Provided by: dmscM
Category:

less

Transcript and Presenter's Notes

Title: Bexarotene Targretin


1
Bexarotene Targretin
  • Drug acts at nuclear receptor

Laksirin Sirisatean 4550076
2
FDA approved
  • Primary cutaneous T-cell lymphoma
  • (CTCL)

3
What is CTCL ?
  • non-Hodgkins lymphoma composed of malignant T
    lymphocytes of the CD4 phenotype
  • serious but uncommon skin condition

4
Pathogenesis
epidermal growth factor
endogeneous INF-?
cell proliferation and differentiation
block T cell
cell cycle and apoptosis
5
Pathogenesis
genetic alteration
CTCL develop
INF-? resistance
epidermal growth factor
defect
cell cycle regulation and apoptosis
T-lymphocyte proliferate
6
Pharmacological effect of retinoid
7
Physiological of RAR-RXR
  • control abnormal cellular process by
  • Modulating cell differentiation
  • Inhibiting cell proliferation
  • Regulating apoptosis

8
CTCL includes
  • Mycosis fungoides
  • Sézary syndrome
  • Follicular cell lymphoma
  • T-cell leukaemia

DermNet Editorial Board Department of Dermatology,
9
Clinical Manifestations
patches
infiltrated plaques
tumors
Journal of the Moffitt Cancer Center
10
Treatment
  • Topical steroids
  • UVB phototherapy
  • PUVA photochemotherapy
  • Topical nitrogen mustard
  • Chemotherapy
  • Localised radiotherapy
  • Electron beam radiotherapy
  • Interferons
  • Oral retinoids
  • Bone marrow / Stem cell transplantation
  • Photopheresis.

11
Bexarotene (Targretin?)
  • First synthetic highly selective RXR retinoid

12
Synthesis
4-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-nap
hthalenyl)-1-propenylbenzoic acid
TTNPB
R
13
Synthesis

AlCl3
14
Synthesis

AlCl3
15
Synthesis

NaNH2 THF
Ph3PCH3Br
16
Synthesis

HCl
KOH, MeOH
17
R

etinoid

RXR Agonist
eceptors
TARGRETIN
18
R
etinoid

Type
eceptors
2 Type
The Retinoic Acid Receptors

The Retinoid X Receptors

19
R
etinoid
eceptors
RXR Receptor Structure
Ligand-Binding Domains

DNA-Binding Domains

20
R
etinoid X

Structure
eceptors
21
R
etinoid X
eceptors
Ligand-Binding Domains
Ligand- Binding Pockets
L-Shaped Form
H3 H5 H7 H11
22
R
etinoid X
eceptors
CH2
R
Drug
23
R
etinoid X
eceptors
24
R
etinoid X

eceptors
DNA-Binding Domains
2-Zinc finger motifs
P box
D box
25
R
etinoid X
eceptors
DNA-Binding Domains
Direct Repeat
5 base-pairs
5
3
26
R
etinoid X
eceptors
DBD Structure
27
R
etinoid X
eceptors
28
R
etinoid X

eceptors
29
Mechanism Of Action
30
R
AR-RXR
HDAC
CoR
RXR
RAR
31
R
AR-RXR
HAT
CoA
Drug
RAR
RXR
Transcription
32
Conclusions
Write a Comment
User Comments (0)
About PowerShow.com